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Table A1 -Effect of Financial Health on Lobbying at the Industry Level
The table reports the OLS regression results where the dependent variable is the growth in lobbying expenses of all entities within the same four-digit NAICS code level (companies and 
Table A3 -Effect of Financial Health on R&D Expenditures
The table reports two-period OLS-based difference-in-differences estimates where the dependent variable is the firm R&D expenditures (normalized by lagged assets). The first (pre-treatment) period is 2008q1 and the second (post-treatment) period is 2009q1. CDS Spread is the spread on the firm's credit default swaps in basis points, Assets are the book value of firm's assets in millions, Market-to-Book is the sum of the market value of the firm's equity and the book value of firm's debt, all divided by the firm's book value of assets. Cash Flow is the quarterly earnings before interest, taxes, depreciation, and amortization scaled by lagged assets. All the stock explanatory variables are as of the beginning of the period; all the flow explanatory variables are as of the previous quarter. Linear industry trends are based on 22 2-digit NAICS classification. Firms that are below the 1 st and above the 99 th percentile in the dependent variable or in the change of CDS Spread are dropped. Active Lobbiers are the firms with strictly positive lobbying expenses for at least one quarter in 2007 or later. Firm fixed effects are absorbed through first differencing before the actual estimation is performed. Heteroscedasticiy-robust standard errors are in parentheses. *, **, *** denote the statistical significance at 10, 5, 1% levels, respectively.
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